GlassScriptPhysician profile
Jianming Dong
NPI 1619981305
$1,177.35
in general payments reported to CMS, 2019-2025
26 companies · $19.95 in 2025
The $19.95 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $914 · 2020: $194 · 2022: $49.40 · 2025: $19.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $256.47 | 2019-2020 | |
| Biogen, INC. | $132.91 | 2019-2020 | |
| Ucb, INC. | $77.68 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $51.98 | 2019 | |
| Eisai INC. | $51.39 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $50.59 | 2019 | |
| Avion Pharmaceuticals | $49.40 | 2022 | |
| Acadia Pharmaceuticals INC | $49.24 | 2019-2020 | |
| Lilly USA, LLC | $47.23 | 2019 | |
| Genzyme Corporation | $37.23 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.60 | 2019 | |
| Sk Life Science, INC. | $33.60 | 2020 | |
| Livanova USA, INC. | $33.01 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $32.84 | 2019 | |
| Amgen INC. | $31.84 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $30.47 | 2019 | |
| Greenwich Biosciences, INC. | $23.87 | 2020 | |
| Adamas Pharmaceuticals, INC. | $21.93 | 2020 | |
| Abbvie INC. | $19.95 | 2025 | |
| Arbor Pharmaceuticals, INC. | $19.02 | 2019 | |
| Acorda Therapeutics, INC | $18.63 | 2019 | |
| Grifols USA, LLC | $16.15 | 2019 | |
| Neurocrine Biosciences, INC. | $16.11 | 2019 | |
| Lundbeck LLC | $14.82 | 2019 | |
| Endo Pharmaceuticals INC. | $14.00 | 2019 | |
| Emd Serono, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jianming Dong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.